Precision Editing: Base Editing, Prime Editing, and Beyond
The Move Toward Precise Sequence Writing
Why Precision Matters
Many applications require exact edits rather than disruption: correcting pathogenic point mutations, installing regulatory variants, or engineering subtle protein substitutions. Precision editors seek to reduce the collateral damage associated with double-strand breaks while expanding the range of addressable changes.
Editor Families
Cytosine and adenine base editors
- Efficient single-base conversion within a targeting window
- Do not typically require double-strand breaks
- Can be limited by bystander edits and sequence constraints
Prime editors
- Encode arbitrary small edits with a templated guide
- Potentially broader edit scope than base editors
- Often challenged by lower efficiency and product heterogeneity
Unresolved Technical Challenges
Key bottlenecks include editing window control, off-target deamination or nicking, indel suppression, editing large insertions, allele selectivity, and predictable performance across cell states. For therapeutic use, one must also consider immunogenicity, persistent editor exposure, and long-term genomic stability.
Sources of Product Heterogeneity
What is a hallmark advantage of base editing over standard nuclease editing?
Base editing is designed to make certain base conversions while avoiding the need to create a double-strand break.
Correct answer: It can often make nucleotide conversions with fewer double-strand-break-associated byproducts
Which limitation is especially associated with many base editors?
Base editors can modify more than one nucleotide within their active window, creating bystander products.
Correct answer: Bystander edits within the editing window
Why is prime editing conceptually described as a search-and-replace technology?
This analogy captures its ability to specify the desired edit rather than merely inducing a break.
Correct answer: Because the guide RNA encodes the intended sequence change and the system writes that sequence into the genome.
Name one reason precision editors may still be difficult to translate therapeutically.
Even precise chemistry can be undermined by poor tissue delivery or mixed editing outcomes.
Correct answer: Delivery and product heterogeneity.
Open Problem
The field still lacks a universally efficient editor for large insertions, precise multi-site rewriting, and highly predictable outcomes across all relevant primary cell types.